What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to officially submit and announce Cigna Group's financial results for the fourth quarter and full year ended December 31, 2024, through a press release furnished as an exhibit.

Where can I find the detailed financial results?

The detailed financial results, including revenue, earnings, and other key performance indicators, are contained within the press release dated January 30, 2025, which is provided as Exhibit 99.1 to this 8-K filing.

Does this filing provide an outlook or guidance for the upcoming year?

This 8-K filing itself does not contain forward-looking guidance. Any outlook or guidance for the upcoming year would be detailed within the press release (Exhibit 99.1) that is furnished with this report.

What is the significance of the information 'shall not be deemed 'filed' for purposes of Section 18'?

This statement means that while the press release is being submitted to the SEC, it is not being incorporated into the company's official SEC filings for liability purposes under Section 18 of the Securities Exchange Act of 1934, unless specifically referenced in another filing. This is a common practice for earnings press releases.

CI 8-K: Earnings & Results

Summary

The Cigna Group (CI) filed an 8-K on January 30, 2025, primarily to furnish a press release announcing its financial results for the three months and full year ended December 31, 2024. While the filing itself does not contain detailed financial figures, it serves as the official mechanism to disseminate these results to the public and the SEC. Investors should refer to the furnished press release (Exhibit 99.1) for comprehensive information on the company's performance, including key financial metrics, operational highlights, and forward-looking statements.

Key Highlights

1Cigna Group announced its financial results for the fourth quarter and full year ended December 31, 2024, via a press release.
2The 8-K filing's primary purpose is to furnish this press release (Exhibit 99.1) to the SEC.
3The filing does not contain detailed financial statements or commentary; these are in the accompanying press release.
4Investors need to review Exhibit 99.1 for specific performance data and management's discussion.
5The information furnished is not considered 'filed' for Section 18 of the Exchange Act, limiting liability for certain forward-looking statements.
6The filing includes the Cover Page Interactive Data File (XBRL) for enhanced data accessibility.

Cigna Group 8-K Report, Financial Results (Jan 30, 2025)

Summary

Key Highlights

Frequently Asked Questions